tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LRMR Stock Latest News

Buy Rating for Larimar Therapeutics Driven by Positive Physician Sentiment and Promising Prospects for Nomlabofusp
RatingsBuy Rating for Larimar Therapeutics Driven by Positive Physician Sentiment and Promising Prospects for Nomlabofusp
3d ago
LRMR
3 Best Stocks to Buy Now, 9/1/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/1/2025, According to Top Analysts
18d ago
APLD
LRMR
Promising Developments and Strategic Timeline Drive Buy Rating for Larimar Therapeutics
PremiumRatings
Promising Developments and Strategic Timeline Drive Buy Rating for Larimar Therapeutics
21d ago
LRMR
Positive Outlook for Larimar Therapeutics: Buy Rating Supported by FDA Decisions and Upcoming Trial Data
PremiumRatings
Positive Outlook for Larimar Therapeutics: Buy Rating Supported by FDA Decisions and Upcoming Trial Data
28d ago
LRMR
Buy Rating for Larimar Therapeutics: Strong Phase 3 Progress, Regulatory Alignment, and Market Advantage
PremiumRatings
Buy Rating for Larimar Therapeutics: Strong Phase 3 Progress, Regulatory Alignment, and Market Advantage
1M ago
LRMR
3 Best Stocks to Buy Now, 8/15/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 8/15/2025, According to Top Analysts
1M ago
CMG
LRMR
Larimar Therapeutics price target lowered to $18 from $22 at Citizens JMP
Premium
The Fly
Larimar Therapeutics price target lowered to $18 from $22 at Citizens JMP
1M ago
LRMR
Promising Advancements and Strategic Positioning Drive Buy Rating for Larimar Therapeutics
Premium
Ratings
Promising Advancements and Strategic Positioning Drive Buy Rating for Larimar Therapeutics
1M ago
LRMR
Larimar Therapeutics Advances Nomlabofusp Program Amid Financial Losses
PremiumCompany Announcements
Larimar Therapeutics Advances Nomlabofusp Program Amid Financial Losses
1M ago
LRMR
Promising Data and Optimistic Outlook Drive Buy Rating for Larimar Therapeutics
PremiumRatings
Promising Data and Optimistic Outlook Drive Buy Rating for Larimar Therapeutics
1M ago
LRMR
Larimar Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Larimar Therapeutics Reports Q2 2025 Financial Results
1M ago
8K
LRMR
Larimar Therapeutics reports Q2 EPS (41c), consensus (49c)
PremiumThe Fly
Larimar Therapeutics reports Q2 EPS (41c), consensus (49c)
1M ago
LRMR
Larimar Therapeutics Announces $64.4 Million Stock Offering
PremiumCompany AnnouncementsLarimar Therapeutics Announces $64.4 Million Stock Offering
2M ago
8K
LRMR
Larimar Therapeutics 18.75M share Spot Secondary priced at $3.20
Premium
The Fly
Larimar Therapeutics 18.75M share Spot Secondary priced at $3.20
2M ago
LRMR
Larimar Therapeutics TBA Spot Secondary; price range $3.20-$3.40
Premium
The Fly
Larimar Therapeutics TBA Spot Secondary; price range $3.20-$3.40
2M ago
LRMR
Larimar Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Larimar Therapeutics announces common stock offering, no amount given
2M ago
LRMR
Promising Potential of Larimar Therapeutics’ Nomlabofusp in Friedreich’s Ataxia: A Buy Rating Justified
PremiumRatings
Promising Potential of Larimar Therapeutics’ Nomlabofusp in Friedreich’s Ataxia: A Buy Rating Justified
2M ago
LRMR
Positive Outlook for Larimar Therapeutics: Promising Data on Nomlabofusp and Anticipated Catalysts Drive Buy Rating
PremiumRatings
Positive Outlook for Larimar Therapeutics: Promising Data on Nomlabofusp and Anticipated Catalysts Drive Buy Rating
2M ago
LRMR
Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA
PremiumThe Fly
Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA
2M ago
LRMR
Promising Regulatory Progress and Market Potential for Larimar Therapeutics
PremiumRatingsPromising Regulatory Progress and Market Potential for Larimar Therapeutics
3M ago
LRMR
Larimar Therapeutics price target lowered to $15 from $17 at Wedbush
Premium
The Fly
Larimar Therapeutics price target lowered to $15 from $17 at Wedbush
3M ago
LRMR
Larimar Therapeutics selloff a buying opportunity, says Citi
Premium
The Fly
Larimar Therapeutics selloff a buying opportunity, says Citi
3M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >